GRAFT-VERSUS-HOST DISEASE, RELAPSE-FREE SURVIVAL (GRFS) IN OLDER PATIENTS WITH MYELOID MALIGNANCIES IS DETERMINED BY DISEASE STAGE AND DONOR AGE BUT NOT BY THE TYPE OF THE DONOR

被引：0
|
作者：
Jindra, Pavel [1 ]
Karas, Michal [2 ]
Cepek, Pavel [1 ]
Steinerova, Katerina [2 ]
Lysak, Daniel [2 ]
机构：
[1] Czech Natl Marrow Donors Registry, Plzen, Czech Republic
[2] Univ Hosp Plzen, Plzen, Czech Republic
来源：
HLA | 2019年 / 93卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P155
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [1] Efficacy of allogeneic haematopoietic transplantation in older patients with myeloid malignancies assessed by Graft-versus-Host Disease Free, Relapse-Free Survival (GRFS). Multivariable Analysis from a Single Centre
    Jindra, Pavel
    Karas, Michal
    Lysak, Daniel
    Jungova, Alexandra
    Steinerova, Katerina
    Marcela, Hrabetova
    Sramek, Jiri
    Zabranska, Tereza
    Mohammadova, Lekka
    Bergerova, Veronika
    BONE MARROW TRANSPLANTATION, 2018, 53 : 163 - 164
  • [2] Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Older Patients with Myeloid Malignancies
    Nazha, Aziz
    Rybicki, Lisa
    Abounader, Donna
    Bolwell, Brian
    Dean, Robert M.
    Ferraro, Christina
    Gerds, Aaron
    Jagadeesh, Deepa
    Hamilton, Betty Ky
    Hill, Brian T.
    Kalaycio, Matt E.
    Liu, Hein
    Pohlman, Brad
    Sobecks, Ronald M.
    Starn, Jamie
    Winslow, Victoria
    Sekeres, Mikkael
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S205 - S206
  • [3] Comparison of Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) of Patients with Hematological Malignancy According to Donor Type: JS']JSHCT Working Group Study
    Inamoto, Yoshihiro
    Kimura, Fumihiko
    Kanda, Junya
    Sugita, Junichi
    Ikegame, Kazuhiro
    Nakasone, Hideki
    Nannya, Yasuhito
    Uchida, Naoyuki
    Fukuda, Takahiro
    Yoshioka, Kosuke
    Ozawa, Yukiyasu
    Kawano, Ichiro
    Atsuta, Yoshiko
    Kato, Koji
    Ichinohe, Tatsuo
    Inoue, Masami
    Teshima, Takanori
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S399 - S400
  • [4] Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Pediatric Patients
    Mehta, Rohtesh S.
    Holtan, Shernan G.
    Wang, Tao
    Hemmer, Michael T.
    Spellman, Stephen R.
    Arora, Mukta
    Couriel, Daniel R.
    Alousi, Amin M.
    Pidala, Joseph
    Weisdorf, Daniel J.
    BLOOD, 2017, 130
  • [5] Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Adults
    Mehta, Rohtesh S.
    Holtan, Shernan G.
    Wang, Tao
    Hemmer, Michael T.
    Spellman, Stephen R.
    Arora, Mukta
    Couriel, Daniel R.
    Alousi, Amin M.
    Pidala, Joseph
    Weisdorf, Daniel J.
    BLOOD, 2017, 130
  • [6] Improved Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) Associated with Bone Marrow as the Stem Cell Source in Adults
    Mehta, Rohtesh S.
    deLatour, Regis Peffault
    Defor, Todd E.
    Robin, Marie
    Lazaryan, Aleksandr
    Xhaard, Alienor
    Bejanyan, Nelli
    de Fontbrune, Flore Sicre
    Arora, Mukta
    Brunstein, Claudio G.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    MacMillan, Margaret L.
    Socie, Gerard
    Holtan, Shernan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S49 - S49
  • [7] Graft-versus-Host Disease-Free Relapse-Free Survival Definition for Patients with Nonmalignant Hematologic Disorders
    Salas, Maria Queralt
    Kumar, Rajat
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (02) : 428 - 428
  • [8] Impact of donor type on long-term graft-versus-host disease-free/relapse-free survival for adult acute lymphoblastic leukemia in first remission
    Yoon, Jae-Ho
    Min, Gi June
    Park, Sung-Soo
    Park, Silvia
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong-Wook
    Lee, Seok
    BONE MARROW TRANSPLANTATION, 2021, 56 (04) : 828 - 840
  • [9] Impact of donor type on long-term graft-versus-host disease-free/relapse-free survival for adult acute lymphoblastic leukemia in first remission
    Jae-Ho Yoon
    Gi June Min
    Sung-Soo Park
    Silvia Park
    Sung-Eun Lee
    Byung-Sik Cho
    Ki-Seong Eom
    Yoo-Jin Kim
    Hee-Je Kim
    Chang-Ki Min
    Seok-Goo Cho
    Jong-Wook Lee
    Seok Lee
    Bone Marrow Transplantation, 2021, 56 : 828 - 840
  • [10] Definition of graft-versus-host disease-free, relapse-free survival (GRFS) for registry based studies. An ALWP- EBMT analysis on patients with acute myeloid leukemia in remission
    Ruggeri, A.
    Labopin, M.
    Ciceri, F.
    Mohty, M.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S5 - S6
12345